Trending...
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
London, Cambridge (UK), Toronto and Niagara-on-the-Lake (Canada) September 8, 2022: AlgoDynamix, the leader in behavioral based price forecasting for financial markets has signed a collaboration agreement with Quant pioneer Dr. Ernie Chan. The agreement covers research, development and productization with a strong initial focus on Crypto. New investment products are expected to be available early Q4 2022.
PrAtlas -- AlgoDynamix and Dr. Ernie Chan, one of the world's renowned Quant Pioneers, have joined forces to combine their respective expertise to co-launch new investment products with an initial focus on Crypto.
Dr. Ernie Chan, "Crypto is a great asset class with lots of potential, though as we have seen in the past few months it can be very challenging!". Dr. Chan continues: "I am delighted to be partnering with the AlgoDynamix team to make the most of this newer asset class, we will announce further updates soon, including new investment product launches in early Q4 this year"
Throughout the last three decades Dr. Chan has transformed the financial services industry using his mathematical rigor. This already started back in the days of his IBM research and continued with ongoing research at the bulge bracket investment banks as well as the smaller more efficient hedge funds. His latest venture includes advanced predictive analytics and partnerships that maximize his decades of multi-asset trading, tail risk management, portfolio construction and flawless trade execution.
More on PrAtlas
Tarun Khanna, President AlgoDynamix North America: "We are absolutely delighted to be working with Dr. Ernie Chan on groundbreaking new Crypto investment products. Our initial discussions with Dr. Chan made it clear that there was definitely an opportunity to work together and to combine the best of all worlds."
Updates and further announcements will be available throughout Q4, please do join AlgoDynamix mailing list for latest updates.
Disclaimers
Press releases and website disclaimers
About AlgoDynamix
Home - AlgoDynamix (UK) overview @ Amadeus Capital Partners
About Dr. Ernest P. Chan
Home - E.P. Chan & Associates (epchan.com)
Dr. Ernie Chan, "Crypto is a great asset class with lots of potential, though as we have seen in the past few months it can be very challenging!". Dr. Chan continues: "I am delighted to be partnering with the AlgoDynamix team to make the most of this newer asset class, we will announce further updates soon, including new investment product launches in early Q4 this year"
Throughout the last three decades Dr. Chan has transformed the financial services industry using his mathematical rigor. This already started back in the days of his IBM research and continued with ongoing research at the bulge bracket investment banks as well as the smaller more efficient hedge funds. His latest venture includes advanced predictive analytics and partnerships that maximize his decades of multi-asset trading, tail risk management, portfolio construction and flawless trade execution.
More on PrAtlas
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
Tarun Khanna, President AlgoDynamix North America: "We are absolutely delighted to be working with Dr. Ernie Chan on groundbreaking new Crypto investment products. Our initial discussions with Dr. Chan made it clear that there was definitely an opportunity to work together and to combine the best of all worlds."
Updates and further announcements will be available throughout Q4, please do join AlgoDynamix mailing list for latest updates.
Disclaimers
Press releases and website disclaimers
About AlgoDynamix
Home - AlgoDynamix (UK) overview @ Amadeus Capital Partners
About Dr. Ernest P. Chan
Home - E.P. Chan & Associates (epchan.com)
Source: AlgoDynamix (UK) Ltd.
0 Comments
Latest on PrAtlas
- NoviSign Sponsoring VARTECH 2025 - the B2B IT channel's #1 event
- Unicorp and BH Group Select Chasing Creative—Palm Coast Agency—to Lead Growth Marketing for The Ritz-Carlton Residences, Hammock Dunes
- Breaking: 50+ runners from 20+ states relay custom 9/11 flag 485 miles from Shanksville through DC to Ground Zero for memorial remembrance run
- SecureMaine 2025 is this October 8th in Portland, Maine
- John Thomas calls for unity and prayer after tragic loss
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution